A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2002
11/06/2002	EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1254113A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
11/06/2002	EP1254106A1 Calcilytic compounds
11/06/2002	EP1253930A2 Method and compositions for treating hepatocellular cancer
11/06/2002	EP1253922A2 Statin-type bone growth stimulators
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002	EP0906338B1 Glucagon-like peptide-2 analogs
11/06/2002	EP0906288B1 New compounds
11/06/2002	EP0741577B1 The use of interferon subtype alpha 8 in the preparation of medicaments to treat viral infections of the liver
11/06/2002	EP0726758B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
11/06/2002	CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378533A Phenoxypropylamine compounds
11/06/2002	CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002	CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002	CN1378528A Use of carbonylamino derivatives against CNS disorders
11/06/2002	CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1378458A Use of TGF-beta and growth factors in treatment and prevention of diseases of intestinal mucosa
11/06/2002	CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/06/2002	CN1377696A Chinese herbal medicine preparation for curing viral hepatitis and its preapring method
11/06/2002	CN1377693A Traditional Chinese medicine wine fore relaxing muscles and tendons and activating blood circulation, expelling wind and stopping pain, and relieving flatulence and relaxing the bowels
11/06/2002	CN1377692A Health nutrient capsule and its preparation and use
11/06/2002	CN1377674A Chinese medicine granule for curing child's diarrhea
11/06/2002	CN1377666A Medicine for curing cholecystitis and its preparing method
11/06/2002	CN1377664A Pill for clearing away liver fire and reducing fat
11/06/2002	CN1377662A Stone expelling pill
11/06/2002	CN1377656A Pancreas recovering liquid
11/06/2002	CN1377650A Medicine for curing cholecystopathy
11/06/2002	CN1377645A Tea polyphenol buccal tablet for preventing and curing tooth decay and its preparing method
11/06/2002	CN1093765C Injection for treating viral hepatitis
11/06/2002	CN1093756C Oral preparations
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002	US6476060 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
11/05/2002	US6476052 Isoindolines, method of use, and pharmaceutical compositions
11/05/2002	US6476043 Use of camptothecin derivatives, with reduced gastrointestinal toxicity
11/05/2002	US6476038 Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476028 Compounds and methods
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6476022 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
11/05/2002	US6476010 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of l-carnitine or salts
11/05/2002	US6475997 Methods of stimulating phagocytosis
11/05/2002	US6475804 Composition and method for diagnosing auto-immune hepatitis
11/05/2002	US6475524 Composition of matter
11/05/2002	US6475512 Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals
11/05/2002	US6475509 Covalent conjugates of sodium channel blockers and active compounds
11/05/2002	US6475493 Controlled release pellet formulation
11/05/2002	CA2324467C Formulations for protection of peg-interferon alpha conjugates
11/05/2002	CA2109322C Bombesin analogs
11/05/2002	CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
11/02/2002	CA2384344A1 4-(2-pyridyl)piperizines having 5ht7 receptor agonist activity
11/01/2002	CA2384227A1 Combination treatment for anxiety and depression
10/2002
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086107A2 A method for differentiating stem cells into insulin-producing cells
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086085A2 Human timp-1 antibodies
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002	WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085897A1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085892A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/31/2002	WO2002085891A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
10/31/2002	WO2002085890A1 Benzimidazolone derivatives
10/31/2002	WO2002085889A1 Crystalline form of omeprazole
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085843A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002	WO2002085839A1 Fused bicyclic or tricyclic amino acids
10/31/2002	WO2002085414A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
10/31/2002	WO2002085412A1 Tissue fibrosis inhibitors
10/31/2002	WO2002085402A1 Methods and compositions for treating oral and eosophageal lesions
10/31/2002	WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002	WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002	WO2002085384A2 Lubricious coatings for substrates
10/31/2002	WO2002085368A2 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
10/31/2002	WO2002085347A1 Preventive/remedial agent for inflammatory disease in oral-cavity mucosa and the like
10/31/2002	WO2002085312A2 Process for purifying 6-methoxy omeprazole
10/31/2002	WO2002085299A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002	WO2002085123A1 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation
10/31/2002	WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002	WO2002053564A3 Quinuclidine derivatives and their use as m3 antagonists
10/31/2002	WO2002051855A3 Motilide compounds
10/31/2002	WO2002049650A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/31/2002	WO2002042455A3 Modifier of organelle metalbolism
10/31/2002	WO2002041896A3 Use of thienopyrimidines

1 ... 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 ... 1258